Sponsor or institution
Clinical trials and research at Oncotherapeutics
As of November 12, 2026, Find a Trial lists 4 clinical trials run by Oncotherapeutics that are recruiting, in United States. By phase: Phase 1 (2), Phase 2 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combination treatment for relapsed or refractory multiple myeloma | Phase 1 | West Hollywood, California | Recruiting | Jan 25, 2024 |
| Using serum BCMA levels to track disease progression in multiple myeloma | Early Phase 1 | West Hollywood, California | Recruiting | Jan 17, 2024 |
| Combining venetoclax with isatuximab and dexamethasone for treating relapsed/refractory multiple myeloma | Phase 2 | West Hollywood, California and 1 other locations | Recruiting | Nov 2, 2023 |
| Combining Ruxolitinib, Steroids, and Lenalidomide for Patients with Relapsed Multiple Myeloma | Phase 1 | Alhambra, California and 12 other locations | Recruiting | Apr 12, 2017 |
All recruiting trials (4)
-
Combination treatment for relapsed or refractory multiple myeloma
This study is testing a new combination of lower-dose Selinexor, Ruxolitinib, and methylprednisolone to see if it can help people with relapsed or refractory multiple myeloma who have few treatment options left.
-
Using serum BCMA levels to track disease progression in multiple myeloma
This study is testing if measuring BCMA levels in the blood can help track how well new treatments work for people with progressive multiple myeloma.
-
Combining venetoclax with isatuximab and dexamethasone for treating relapsed/refractory multiple myeloma
This study is testing a new combination of medications to see if it can help people with relapsed or stubborn multiple myeloma who have a specific genetic marker feel better and respond to treatment.
-
Combining Ruxolitinib, Steroids, and Lenalidomide for Patients with Relapsed Multiple Myeloma
This study is testing a new combination of ruxolitinib, steroids, and lenalidomide to see if it can help people with relapsed multiple myeloma feel better and improve their treatment results.
Quick answers
How many clinical trials run by Oncotherapeutics are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.